|
Volumn 16, Issue 5, 2001, Pages 173-177
|
Effect of IL-15 on the secretion of IL-1β, IL-1Ra and sIL-1RII by PMN from cancer patients
|
Author keywords
Interleukin 1 beta; Interleukin 1 receptor antagonist; Interleukin 15; Neutrophil; Soluble interleukin 1 receptor type II
|
Indexed keywords
INTERLEUKIN 1 RECEPTOR;
INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
INTERLEUKIN 15;
INTERLEUKIN 1BETA;
LIPOPOLYSACCHARIDE;
RECEPTOR SUBTYPE;
RECOMBINANT INTERLEUKIN 15;
ARTICLE;
CANCER IMMUNOTHERAPY;
CANCER PATIENT;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CYTOKINE RELEASE;
DRUG EFFECT;
HUMAN;
HUMAN CELL;
LEUKOCYTE ACTIVATION;
MELANOMA;
MOUTH CARCINOMA;
NEUTROPHIL;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
|
EID: 0035824888
PISSN: 10434666
EISSN: None
Source Type: Journal
DOI: 10.1006/cyto.2001.0931 Document Type: Article |
Times cited : (16)
|
References (15)
|